Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
• To demonstrate that GSK Biologicals’ dTpa-IPV vaccine is non-inferior to Sanofi Pasteur MSD’s dTpa-IPV vaccine in terms of percentages of subjects with immune response to the diphtheria, tetanus and polio antigens, one month after booster vaccination. • To demonstrate that GSK Biologicals’ dTpa-IPV vaccine given as a single booster dose in this study is non-inferior to GSK Biologicals’ DTPa vaccine (Infanrix) given as a primary series in the German household contact study APV-039 in terms of anti- PT, anti-FHA and anti-PRN geometric mean concentrations (GMCs), one month after booster vaccination.
Inclusion criteria
- Booster immunisation against diphtheria, tetanus, pertussis, poliomyelitis, measles, mumps and rubella in healthy preschool children previously vaccinated with 3 doses of DTPa and polio vaccine